Cargando…
Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening
ATAD2 has been reported to play an important role in the processes of numerous cancers and validated to be a potential therapeutic target. This work is to discover potent ATAD2 inhibitors and elucidate the underlying mechanisms in breast cancer. A novel ATAD2 bromodomain inhibitor (AM879) was discov...
Autores principales: | Yao, Dahong, Zhang, Jin, Wang, Jinhui, Pan, Dabo, He, Zhendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144325/ https://www.ncbi.nlm.nih.gov/pubmed/32174193 http://dx.doi.org/10.1080/14756366.2020.1740924 |
Ejemplares similares
-
Fragment-Based Screening of
the Bromodomain of ATAD2
por: Harner, Mary J., et al.
Publicado: (2014) -
Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
por: Evans, Chiara M., et al.
Publicado: (2021) -
ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
por: Fu, Jiahui, et al.
Publicado: (2023) -
Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells
por: Yao, Dahong, et al.
Publicado: (2023) -
Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer
por: Yao, Dahong, et al.
Publicado: (2020)